FDA Grants Abbott Marketing Clearance for Zika Virus Test

February 2, 2017

The FDA has authorized marketing of Abbott’s real-time Zika test, which is used to detect Zika virus in whole blood for emergency use.

The test is designed for use on the m2000 real-time system and it provides results within five to seven hours. — Cynthia Jessup

View today's stories